Related Experiment Video
Updated: Jun 17, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.6K
GENETIC DETERMINANTS OF THROMBOSIS
1BALTIMORE, MARYLAND.
Summary
Genetic variants contribute to venous thromboembolism (VTE), a significant health issue. Genome-wide association studies (GWAS) are identifying new genetic factors and pathways for VTE, potentially leading to novel therapies.
Area of Science:
- Genetics
- Thrombosis
- Molecular Biology
Background:
- Venous thromboembolism (VTE) represents a substantial cause of illness and death in the US.
- While both genetic and acquired factors contribute to VTE, the specific genetic variants influencing risk remain incompletely understood.
- Recent advancements in genetic research have begun to elucidate the underlying mechanisms of VTE.
Purpose of the Study:
- To explore the genetic underpinnings of venous thromboembolism (VTE).
- To identify novel genetic loci associated with VTE through genome-wide association studies (GWAS).
- To investigate the functional roles of candidate genes identified by GWAS in VTE pathogenesis.
Main Methods:
- Utilizing genome-wide association studies (GWAS) to identify genetic variants associated with VTE.
- Performing functional characterization of candidate genes discovered through GWAS.
- Analyzing newly uncovered pathways involved in the regulation of VTE.
Main Results:
- Genome-wide association studies (GWAS) have successfully identified several novel genetic loci linked to VTE.
- Initial characterization of these loci has revealed previously unknown biological pathways implicated in VTE.
- Candidate genes emerging from GWAS present potential targets for further investigation.
Conclusions:
- Genetic variants play a critical role in the development of venous thromboembolism (VTE).
- GWAS are instrumental in discovering novel genetic factors and pathways relevant to VTE.
- Functional studies of GWAS-identified genes may yield new therapeutic strategies for thrombosis and bleeding disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Disorders of Hemostasis
768
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
768
Extrinsic and Intrinsic Pathways of Hemostasis
6.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.7K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Clot Retraction and Fibrinolysis
5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K

